ABS® Global, Inc. signed an agreement for the acquisition of 51% of In Vitro Brasil S.A. (IVB®), a biotechnology company focused on the production of bovine embryos through in-vitro fertilization (IVF). IVB is based in Brazil and operates in 13 countries, including the United States, Colombia and Uruguay.

IVB is headquartered in Mogi Mirim, São Paulo state, Brazil, and operates through wholly owned labs, joint ventures, and franchise agreements. It was established in 2002 by José Henrique F. Pontes, currently CEO of IVB, to meet the need for bovine IVF technology from commercial dairy and beef producers in Brazil. Today, IVB is the primary commercial provider of bovine IVF embryos with a leading presence in Brazil, the globe’s largest bovine IVF market, and a growing presence in other Latin American countries and the United States.

Headquartered in DeForest, Wis., ABS Global, Inc., is a provider of bovine genetics, reproduction services, artificial insemination technologies, and udder care products. Founded in 1941, it markets in more than 70 countries.